Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Abdul Rasheed Mohammed"'
Autor:
Ramakrishna Nirogi, Ilayaraja Kalaikadhiban, Lakshmi Prasanna Rayapati, Hanumanth Rao Pantangi, Prathyusha Chunduru, Satish Jetta, Avinash Jubre, Abdul Rasheed Mohammed
Publikováno v:
Journal of Chromatography Open, Vol 3, Iss , Pp 100073- (2023)
SUVN-911 (Ropanicant) is a novel alpha-4 beta-2 nicotinic acetylcholine receptor (α4β2 nAChR) antagonist being developed for the treatment of major depressive disorders (MDD). An Ultra high-performance liquid chromatography-tandem mass spectrometry
Externí odkaz:
https://doaj.org/article/ea9e09b796bd4eacb6f7dfaae3a236aa
Autor:
Ramakrishna Nirogi, Pradeep Jayarajan, Anil Shinde, Abdul Rasheed Mohammed, Venkata Ramalingayya Grandhi, Vijay Benade, Vinod Kumar Goyal, Renny Abraham, Venkat Jasti, Jeffrey Cummings
Publikováno v:
Biomolecules, Vol 13, Iss 2, p 309 (2023)
Serotonin (5-HT) plays an important role in the regulation of several basic functions of the central and peripheral nervous system. Among the 5-HT receptors, serotonin-6 (5-HT6) receptor has been an area of substantial research. 5-HT6 receptor is a G
Externí odkaz:
https://doaj.org/article/ffb38ef38eaf41d680d033f6aa4d190b
Publikováno v:
PAMM: Proceedings in Applied Mathematics & Mechanics; Oct2024, Vol. 24 Issue 3, p1-9, 9p
Autor:
Moir, John, Kaufmann, Gabriel, Rodriguez, Sarah H., Nourian, Niloofaralsadat, Abdul Rasheed, Mohammed, Vupparaboina, Kiran Kumar, Chhablani, Jay, Skondra, Dimitra
Publikováno v:
Ophthalmic Surgery, Lasers & Imaging Retina; Apr2024, Vol. 55 Issue 4, p30-38, 9p
Publikováno v:
Geology, Ecology & Landscapes; Dec2023, Vol. 7 Issue 4, p281-292, 12p
Autor:
Ramakrishna Nirogi, Vijay Benade, Vinod Kumar Goyal, Santosh Kumar Pandey, Abdul Rasheed Mohammed, Anil Shinde, Dhanunjay Dogiparti, Jyothsna Ravula, Satish Jetta, Veera Raghava Chowdary Palacharla
Publikováno v:
Clinical Drug Investigation. 42:747-762
Ropanicant hydrochloride (previously known as SUVN-911, hereinafter referred to as ropanicant) is a novel alpha4 beta2 nicotinic acetylcholine receptor (α4β2 nAchR) antagonist being developed for the treatment of major depressive disorder. The obje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90b0a8cb608da7795f4cc3a4b2fbb5b9
https://doi.org/10.1007/s40261-022-01189-9
https://doi.org/10.1007/s40261-022-01189-9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Surya Prakash Koidala, Shanmukh Reddy Manne, Kalah Ozimba, Abdul Rasheed Mohammed, Sarforaz Bin Bashar, Nasar Ibrahim Mohammed, Amrish Selvam, Jose Alain Sahel, Jay Chhablani, Soumya Jana, Kiran Kumar Vupparaboina
Various vision-threatening eye diseases including age-related macular degeneration (AMD) and central serous chorioretinopathy(CSCR) are caused due to the dysfunctions manifested in the highly vascular choroid layer of the posterior segment of the eye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d10920008dc004c953279abfb8074d1b
https://doi.org/10.21203/rs.3.rs-2155838/v1
https://doi.org/10.21203/rs.3.rs-2155838/v1
Publikováno v:
ISSUE=25;TITLE=25th Engineering Mechanics Symposium, EM 2022
Poster presentation at the 25th Engineering Mechanics Symposium, hosted by the Graduate School on Engineering Mechanics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::919cf076efa639e451cedd9124baf44c
https://research.utwente.nl/en/publications/673a37ae-40ee-406c-950f-7db5fdb04fc0
https://research.utwente.nl/en/publications/673a37ae-40ee-406c-950f-7db5fdb04fc0
Autor:
Ramakrishna Nirogi, Pradeep Jayarajan, Vijay Benade, Anil Shinde, Vinod Kumar Goyal, Satish Jetta, Jyothsna Ravula, Renny Abraham, Venkata Ramalingayya Grandhi, Ramkumar Subramanian, Santosh Kumar Pandey, Rajesh Kumar Badange, Abdul Rasheed Mohammed, Venkat Jasti, Clive Ballard, Jeffrey Cummings
Publikováno v:
International Journal of Geriatric Psychiatry. 37
The effects of masupirdine on the neuropsychiatric symptoms were explored.Masupirdine (SUVN-502) was evaluated for its effects on cognition in patients with moderate AD. The prespecified primary outcome showed no drug-placebo difference. Post hoc ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9c1875b71599152ba90ab4d2f2a5e2b
https://doi.org/10.1002/gps.5813
https://doi.org/10.1002/gps.5813